期刊文献+

糖尿病与高血压 被引量:38

Diabetes and Hypertension
原文传递
导出
作者 傅祖植
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2005年第5期i0015-i0017,共3页 Chinese Journal of Endocrinology and Metabolism
  • 相关文献

参考文献14

  • 1Barnett AH, et al (eds). Hypertension and Diabetes. 3rd ed. London: Science Press, 2000. 被引量:1
  • 2Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003,289:2560-2572. 被引量:1
  • 3Kannel WB, D'Agostino RB, Wilson PW, et al. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J, 1990,120:672-676. 被引量:1
  • 4Hypertension in Diabetes Study (HDS): Ⅱ. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens, 1993,11:319-325. 被引量:1
  • 5Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ, 1998,317:713-720. 被引量:1
  • 6Moor TJ. DASH diet. Curr Opin Endocrinol Diabetes, 2004,11:158-163. 被引量:1
  • 7Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens, 2000,18:1149-1154. 被引量:1
  • 8ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 2002,288:2981-2997. 被引量:1
  • 9Julius S. The Hypertension Optimal Treatment (HOT) Study in the United States. Am J Hypertens, 1996,9:41S-44S. 被引量:1
  • 10Baba S; J-MIND Study Group. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics. Diabetes Res Clin Pract, 2001,54:191-201. 被引量:1

同被引文献249

引证文献38

二级引证文献212

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部